| Reprogramming exosomes as nanoscale controllers of cellular immunity Q Cheng, X Shi, M Han, G Smbatyan, HJ Lenz, Y Zhang Journal of the American Chemical Society 140 (48), 16413-16417, 2018 | 225 | 2018 |
| Smad7 protein interacts with receptor-regulated Smads (R-Smads) to inhibit transforming growth factor-β (TGF-β)/Smad signaling X Yan, H Liao, M Cheng, X Shi, X Lin, XH Feng, YG Chen Journal of Biological Chemistry 291 (1), 382-392, 2016 | 203 | 2016 |
| Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy X Shi, Q Cheng, T Hou, M Han, G Smbatyan, JE Lang, AL Epstein, ... Molecular Therapy 28 (2), 536-547, 2020 | 163 | 2020 |
| Reprogramming Exosomes for Immunotherapy Q Cheng, X Shi, Y Zhang Cell Reprogramming for Immunotherapy, 197-209, 2020 | 25 | 2020 |
| A bacterial genetic selection system for ubiquitylation cascade discovery O Levin-Kravets, N Tanner, N Shohat, I Attali, T Keren-Kaplan, ... Nature methods 13 (11), 945-952, 2016 | 20 | 2016 |
| Reprogramming extracellular vesicles with engineered proteins X Shi, Q Cheng, Y Zhang Methods 177, 95-102, 2020 | 17 | 2020 |
| Expanding the toolbox of exosome-based modulators of cell functions Q Cheng, Z Dai, X Shi, X Duan, Y Wang, T Hou, Y Zhang Biomaterials 277, 121129, 2021 | 16 | 2021 |
| A poly-ADP-ribose polymer-based antibody-drug conjugate X Shi, XN Zhang, J Chen, Q Cheng, H Pei, SG Louie, Y Zhang Chemical Science 11 (34), 9303-9308, 2020 | 12 | 2020 |
| A humanized antibody inhibitor for cathepsin L X Shi, Y Zhang Protein Science 29 (9), 1924-1930, 2020 | 5 | 2020 |
| Synthetic extracellular vesicles for novel therapies Y Zhang, X Shi, Q Cheng US Patent App. 16/634,857, 2020 | 2* | 2020 |
| Multiple Generations of Capsids Engineered in NHPs Yield Improved Performance in the Central Nervous System B Wheeler, T Sandberg, X Shi, R Elteriefi, M Ling, K McDowell, K Lam, ... MOLECULAR THERAPY 30 (4), 241-241, 2022 | | 2022 |
| Combinatorial Engineering Across Multiple Surface Exposed Loops of AAV2 and AAV9 Yields Capsids with High Degrees of Enrichment and Specificity for Target Tissues TE Sandberg, BG Wheeler, X Shi, R Elteriefi, MX Ling, NC Flytzanis, ... MOLECULAR THERAPY 30 (4), 427-427, 2022 | | 2022 |
| Next-Generation Automated AAV Engineering Platform for Rapid Identification of Efficient and Specific Capsids in Non Human Primates T Sandberg, B Wheeler, C Olson, F Wu, X Shi, R Elteriefi, M Ling, ... MOLECULAR THERAPY 30 (4), 425-425, 2022 | | 2022 |
